Kathrin Gans
5Patents
1h-index
18Co-inventors
40Inventor score
Filing activity: Jul 10, 2009 → Jul 23, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8058405B2 | Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptides | Physics | 35 | Active |
| US8889709B2 | Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditions | Chemistry; Metallurgy | 0 | Active |
| US9157918B2 | Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) | Chemistry; Metallurgy | 0 | Active |
| US8518406B2 | Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) | Chemistry; Metallurgy | 0 | Active |
| US9156907B2 | Diagnostic antibody assay | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.